The information provided on this site is general education information and does not take the place of advice from your doctor, pharmacist or nurse. Please always follow your healthcare professional’s instructions and talk with
him/her about any questions or problems you have regarding your health and treatment
Before Reading on, please make sure that you have been -
- Diagnosed with a form of Lung cancer called non-small cell lung cancer (NSCLC) & prescribed Lumykras™ ▼ (sotorasib) by your doctor
Welcome
This page has been designed to provide you with information to support your on-going treatment with sotorasib. Please have a look over the resources below. If you have further questions about your treatment or general health whilst on
Lumykras™ (sotorasib), always remember to speak to your doctor, nurse or pharmacist.
Lumykras™ ▼ (sotorasib) Patient Guide:
This guide is for adult patients prescribed Lumykras™ to provide more information about your treatment. It covers topics such as:
- Understanding KRAS G12C-mutated NSCLC
- What is Lumykras™ and how does it work?
- What do you need to know before you take Lumykras™?
- How do I take Lumykras™ and when?
- Important safety information
- Storage and contents of Lumykras™
- Definitions
CLICK HERE
OR SCAN THE QR CODE TO DOWNLOAD THE PATIENT GUIDE
Alternatively, please request a printed copy from your doctor, nurse or pharmacist
Lumykras™ ▼ Patient Information Leaflet or PIL
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack
may differ from this version because it may have been updated since your medicine was packaged.
Please read this to ensure you are aware of the full list of side effects and other considerations whilst on your treatment.
CLICK HERE OR SCAN THE QR CODE TO READ THE PATIENT INFORMATION LEAFLET (PIL)
Reporting of Side Effects:
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist, or nurse. This
includes any possible side effects not listed in this guide or the patient information leaflet that comes with your medicine. By reporting side effects, you can help provide more information on the safety of this medicine (see details
below)
Reporting side effects: if you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via
the Yellow Card Scheme at https://yellowcard.mhra.gov.uk.
If you think there may be a defect or quality issue with the Amgen product you have received, please call us on 01223 436441 and provide us with the details. Please ensure that you keep your packaging, so we are able to identify
your product more easily.